Protective immunity against malaria by 'natural immunization': A question of dose, parasite diversity, or both?

Current Opinion in Immunology

Volumn 23, Issue 4, 2011, Pages 500-508

  Borrmann, Steffen ^a,b   Matuschewski, Kai ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; OXYTETRACYCLINE;

ANOPHELES; ANTIGEN DETECTION; BIOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; EFFECTOR CELL; ERYTHROCYTE; GENE FREQUENCY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; MALARIA; MALARIA CONTROL; MEMORY CELL; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; REVIEW; SEQUENCE HOMOLOGY; SPECIES DIVERSITY; SPOROZOITE; VACCINATION;

ANIMALS; ANOPHELES; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CATTLE; CATTLE DISEASES; CHILD; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNITY, HERD; IMMUNITY, INNATE; INSECT BITES AND STINGS; INSECT VECTORS; LIVER; MALARIA; MALARIA VACCINES; MALARIA, FALCIPARUM; MODELS, ANIMAL; PLASMODIUM FALCIPARUM; RECURRENCE; RODENTIA; SPECIES SPECIFICITY; THEILERIASIS; VACCINATION;

EID: 80052378934     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.05.009     Document Type: Review

References (79)

1. Amino R., Thiberge S., Martin B., Celli S., Shorte S., Frischknecht R., Ménard R. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 2008, 12:220-224.
2. Mackintosh C.L., Beeson J.G., Marsh K. Clinical features and pathogenesis of severe malaria. Trends Parasitol 2004, 20:597-603.
3. Paul R.E., Packer M.J., Walmsley M., Lagog M., Ranford-Cartwright L.C., Paru R., Day K.P. Mating patterns in malaria parasite populations of Papua New Guinea. Science 1995, 269:1709-1711.
4. Conway D.J., Roper C., Oduola A.M., Arnot D.E., Kremsner P.G., Grobusch M.P., Curtis C.F., Greenwood B.M. High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A 1999, 96:4506-4511.
5. Anderson T.J., Haubold B., Williams J.T., Estrada-Franco J.G., Richardson L., Mollinedo R., Bockarie M., Mokili J., Mharakurwa S., French N., et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 2000, 17:1467-1482.
6. Volkman S.K., Sabeti P.C., DeCaprio D., Neafsey D.E., Schaffner S.F., Milner D.A., Daily J.P., Sarr O., Ndiaye D., Ndir O., et al. A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 2007, 39:113-119.
7. Su X., Hayton K., Wellems T.E. Genetic linkage and association analyses for trait mapping in Plasmodium falciparum. Nat Rev Genet 2007, 8:497-506.
8. Bull P.C., Buckee C.O., Kyes S., Kortok M.M., Thathy V., Guyah B., Stoute J.A., Newbold C.I., Marsh K. Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocks. Mol Microbiol 2008, 68:1519-1534.
9. Juliano J.J., Porter K., Mwapasa V., Sem R., Rogers W.O., Ariey F., Wongsrichanalai C., Read A., Meshnick S.R. Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing. Proc Natl Acad Sci U S A 2010, 107:20138-20143.
10. Warimwe G.M., Keane T.M., Fegan G., Musyoki J.N., Newton C.R., Pain A., Berriman M., Marsh K., Bull P.C. Plasmodium falciparum var gene expression is modified by host immunity. Proc Nat Acad Sci U S A 2009, 106:21801-21806.
11. Koch R. Dritter Bericht über die Tätigkeit der Malaria-Expedition. Dtsch Med Wochenschr 1900, 26:281-284. (English translation in: Brit Med J 1900, May 12: 1183-1186).
12. Langhorne J., Ndungu F.M., Sponaas A.M., Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008, 9:725-732.
13. Marsh K., Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006, 28:51-60.
14. Crompton P.D., Kayala M.A., Traore B., Kayentao K., Ongoiba A., Weiss G.E., Molina D.M., Burk C.R., Waisberg M., Jasinskas A., et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 2010, 107:6958-6963.
15. Struik S.S., Riley E.M. Does malaria suffer from lack of memory?. Immunol Rev 2004, 201:268-290.
16. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., Kemble G., Connor E.M. Live attenuated versus inactivated influenza vaccine in infants and young children. New Engl J Med 2007, 356:685-696.
17. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 2003, 21:1776-1779.
18. Meeusen E.N., Walker J., Peters A., Pastoret P.P., Jungersen G. Current status of veterinary vaccines. Clin Microbiol Rev 2007, 20:489-510.
19. Di Giulio G., Lynen G., Morzaria S., Oura C., Bishop R. Live immunization against East Coast fever-current status. Trends Parasitol 2009, 25:85-92.
20. Morrison W.I., Goddeeris B.M., Teale A.J. Bovine cytotoxic T cell clones which recognize lymphoblasts infected with two antigenically different stocks of the protozoan parasite Theileria parva. Eur J Immunol 1987, 17:1703-1709.
21. McKeever D.J., Taracha E.L., Morrison W.I., Musoke A.J., Morzaria S.P. Protective immune mechanisms against Theileria parva: evolution of vaccine development strategies. Parasitol Today 1999, 15:263-267.
22. Sergent E. Sur l' immunité dans le paludisme des oiseaux. Conservation in vitro des sporozoites de Plasmodium relictum. Immunité relative obtenue par inoculation de ces sporozoites. C R Acad Sci 1910, 151:407-409.
23. Nussenzweig R.S., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216:160-162.
24. Carvalho L.H., Sano G., Hafalla J.C., Morrot A., Curotto de Lafaille M.A., Zavala F. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat Med 2002, 8:166-170.
25. Berenzon D., Schwenk R.J., Letellier L., Guebre-Xabier M., Williams J., Krzych U. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogenous liver memory CD8+ T cells. J Immunol 2003, 171:2024-2034.
26. Chakravarty S., Cockburn I.A., Kuk S., Overstreet M.G., Sacci J.B., Zavala F. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med 2007, 13:1035-1041.
27. Perlaza B.L., Sauzet J.P., Brahimi K., Benmohamed L., Druilhe P. Interferon-gamma, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity. Malaria J 2011, 10:27.
28. Schmidt N.W., Butler N.S., Badovinac V.P., Harty J.T. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog 2010, 6:e1000998.
29. Schmidt N.W., Harty J.T. Cutting edge: attrition of Plasmodium-specific memory CD8T cells results in decreased protection that is rescued by booster immunization. J Immunol 2011, 186:3836-3840.
30. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., Sacci J., de la Vega P., Dowler M., Paul C., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185:1155-1164.
31. Hoffman S.L., Billingsley P.F., James E., Richman A., Loyevsky M., Li T., Chakravarty S., Gunasekera A., Chattopadhyay R., Li M., et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 2010, 6:97-106.
32. Beaudoin R.L., Strome C.P., Mitchell F., Tubergen T.A. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp Parasitol 1977, 42:1-5.
33. Golenser J., Heeren J., Verhave J.P., Kaay H.J., Meuwissen J.H. Crossreactivity with sporozoites, exoerythrocytic forms and blood schizonts of Plasmodium berghei in indirect fluorescent antibody tests with sera of rats immunized with sporozoites or infected blood. Clin Exp Immunol 1977, 29:43-51.
34. Orjih A.U., Cochrane A.H., Nussenzweig R.S. Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans R Soc Trop Med Hyg 1982, 76:57-61.
35. Belnoue E., Voza T., Costa F.T., Gruner A.C., Mauduit M., Rosa D.S., Depinay N., Kayibanda M., Vigario A.M., Mazier D., et al. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 2008, 181:8552-8558.
36. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., Teelen K., Arens T., et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009, 361:468-477.
37. Roestenberg M., Teirlinck A.C., McCall M.B., Teelen K., Makamdop K.N., Wiersma J., Arens T., Beckers P., van Gemert G., van de Vegte-Bolmer M., et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011, 377:1770-1776.
38. Osier F.H., Fegan G., Polley S.D., Murungi L., Verra F., Tetteh K.K., Lowe B., Mwangi T., Bull P.C., Thomas A.W., et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008, 76:2240-2248.
39. Wootton J.C., Feng X., Ferdig M.T., Cooper R.A., Mu J., Baruch D.I., Magill A.J., Su X.Z. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
40. Friesen J., Silvie O., Putrianti E.D., Hafalla J.C., Matuschewski K., Borrmann S. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2010, 2:40ra49.
41. Putrianti E.D., Silvie O., Kordes M., Borrmann S., Matuschewski K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 2009, 199:899-903.
42. Friesen J., Borrmann S., Matuschewski K. Induction of anti-malaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother 2011, 55:2760-2767.
43. Chilengi R. Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?. Hum Vaccin 2009, 5:627-636.
44. Mueller A.K., Labaied M., Kappe S.H., Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433:164-167.
45. Mueller A.K., Camargo N., Kaiser K., Andorfer C., Frevert U., Matuschewski K., Kappe S.H. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A 2005, 102:3022-3027.
46. van Dijk M.R., Douradinha B., Franke-Fayard B., Heussler V., van Dooren M.W., van Schaijk B., van Gemert G.J., Sauerwein R.W., Mota M.M., Waters A.P., et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A 2005, 102:12194-12199.
47. Matuschewski K., Hafalla J.C., Borrmann S., Friesen J. Arrested Plasmodium liver stages as experimental anti-malaria vaccines. Hum Vaccin 2011, 7(Suppl. 1):16-21.
48. Hoffman S.L., Oster C.N., Plowe C.V., Woollett G.R., Beier J.C., Chulay J.D., Wirtz R.A., Hollingdale M.R., Mugambi M. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 1987, 237:639-642.
49. Orjih A.U., Nussenzweig R.S. Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection. Clin Exp Immunol 1979, 38:1-8.
50. Ocana-Morgner C., Mota M.M., Rodriguez A. Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med 2003, 197:143-151.
51. Gueirard P., Tavares J., Thiberge S., Bernex F., Ishino T., Milon G., Franke-Fayard B., Janse C.J., Ménard R., Amino R. Development of the malaria parasite in the skin of the mammalian host. Proc Natl Acad Sci U S A 2010, 107:18640-18645.
52. Boyd M. Criteria of immunity and susceptibility in naturally induced vivax malaria infections. Am J Trop Med Hyg 1942, 22:217-226.
53. Cox F.E., Voller A. Cross-immunity between the malaria parasites of rodents. Ann Trop Med Parasitol 1966, 60:297-303.
54. Douradinha B., Mota M.M., Luty A.J., Sauerwein R.W. Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?. Infect Immun 2008, 76:873-878.
55. Bull P.C., Lowe B.S., Kortok M., Molyneux C.S., Newbold C.I., Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 1998, 4:358-360.
56. Barry A.E., Leliwa-Sytek A., Tavul L., Imrie H., Migot-Nabias F., Brown S.M., McVean G.A., Day K.P. Population genomics of the immune evasion (var) genes of Plasmodium falciparum. PLoS Pathog 2007, 3:e34.
57. Nussenzweig R.S., Vanderberg J.P., Most H., Orton C. Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites. Nature 1969, 222:488-489.
58. Enosse S., Dobano C., Quelhas D., Aponte J.J., Lievens M., Leach A., Sacarlal J., Greenwood B., Milman J., Dubovsky F., et al. RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials 2006, 1:e5.
59. Douradinha B., van Dijk M.R., Ataide R., van Gemert G.J., Thompson J., Franetich J.F., Mazier D., Luty A.J., Sauerwein R., Janse C.J., et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 2007, 37:1511-1519.
60. Purcell L.A., Wong K.A., Yanow S.K., Lee M., Spithill T.W., Rodriguez A. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 2008, 26:4880-4884.
61. Mackinnon M.J., Marsh K. The selection landscape of malaria parasites. Science 2010, 328:866-871.
62. Matuschewski K., Ross J., Brown S., Kaiser K., Nussenzweig V., Kappe S.H.I. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J Biol Chem 2002, 277:41948-41953.
63. Lasonder E., Janse C.J., van Gemert G.J., Mair G.R., Vermunt A.M., Douradinha B.G., van Noort V., Huynen M.A., Luty A.J., Kroeze H., et al. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog 2008, 4:e1000195.
64. Sauerwein R.W., Roestenberg M., Moorthy V.S. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol 2011, 11:57-64.
65. Trape J.F., Rogier C., Konate L., Diagne N., Bouganali H., Canaque B., Legros F., Badji A., Ndiaye G., Ndiaye P., et al. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 1994, 51:123-137.
66. Bradley-Moore A.M., Greenwood B., Bradley A.K., Bartlett A., Bidwell D.E., Voller A., Kirkwood B.R., Gilles H.M. Malaria chemoprophylaxis with chloroquine in young Nigerian children. I. Its effects on mortailty, morbidity and the prevalence of malaria. Ann Trop Med Parasitol 1985, 79:549-562.
67. Beier J.C., Davis J.R., Vaughan J.A., Noden B.H., Beier M.S. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. Am J Trop Med Hyg 1991, 44:564-570.
68. Trape J.F., Rogier C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 1996, 12:236-240.
69. Snow R.W., Omumbo J.A., Lowe B., Molyneux C.S., Obiero J.O., Palmer A., Weber M.W., Pinder M., Nahlen B., Obonyo C., et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997, 349:1650-1654.
70. Smith T.A., Leuenberger R., Lengeler C. Child mortality and malaria transmission intensity in Africa. Trends Parasitol 2001, 17:145-149.
71. Owusu-Agyei S., Koram K.A., Baird J.K., Utz G.C., Binka F.N., Nkrumah F.K., Fryauff D.J., Hoffman S.L. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg 2001, 65:197-203.
72. Greenwood B.M., Bradley-Moore A.M., Bryceson A.D., Palit A. Immunosuppression in children with malaria. Lancet 1972, 1:169-172.
73. Urban B.C., Ferguson D.J., Pain A., Willcox N., Plebanski M., Austyn J.M., Roberts D.J. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999, 400:73-77.
74. Guilbride D.L., Gawlinski P., Guilbride P.D.L. Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS ONE 2010, 5:e10685.
75. Mazier D., Renia L., Snounou G. A pre-emptive strike against malaria's stealthy hepatic forms. Nat Rev Drug Discov 2009, 8:854-864.
76. Voza T., Kebaier C., Vanderberg J.P. Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity. Malaria J 2010, 9:362.
77. Inoue M., Culleton R.L. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies. Parasite Immunol 2011, 33:137-142.
78. Kester K.E., McKinney D.A., Tornieporth N., Ockenhouse C.F., Heppner D.G., Hall T., Wellde B.T., White K., Sun P., Schwenk R., et al. A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naice adults. Vaccine 2007, 25:5359-5366.
79. Cohen J., Nussenzweig V., Nussenzweig R., Vekemans J., Leach A. From the circumsporozoite protein to the RTS,S/AS candidate vaccine. Hum Vaccin 2010, 6:90-96.